05/08/2024
4:13 PM | INTRACOASTAL CAPITAL, LLC (Filed by)
TFF Pharmaceuticals (Subject)
| Form SC 13G | |
05/08/2024
3:26 PM | CARLSON CAPITAL L P (Filed by)
TFF Pharmaceuticals (Subject)
| Form SC 13G/A | |
05/06/2024
11:15 PM | TFF Pharmaceuticals (Filer)
| Form EFFECT | |
05/01/2024
9:54 AM | TFF Pharmaceuticals (Filer)
| Form 424B4 | |
04/29/2024
11:15 PM | TFF Pharmaceuticals (Filer)
| Form EFFECT | |
04/29/2024
6:15 AM | TFF Pharmaceuticals (Filer)
| Form S-1/A | |
04/29/2024
5:06 AM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
04/25/2024
3:32 PM | TFF Pharmaceuticals (Filer)
| Form S-1/A | |
04/22/2024
7:49 PM | Mikhak Zamaneh (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:49 PM | COLEMAN KIRK ALLEN (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:50 PM | Roberts Brandi (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:51 PM | MILLS ROBERT S (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:52 PM | Lee Catherine Chai-zon (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:52 PM | Patane Michael A (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:53 PM | KING THOMAS BRAXTON (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:47 PM | TFF Pharmaceuticals (Issuer)
Weisman Harlan F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:48 PM | ROCAMBOLI STEPHEN (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
3:24 PM | TFF Pharmaceuticals (Filer)
| Form ARS | |
04/22/2024
3:24 PM | TFF Pharmaceuticals (Filer)
| Form ARS | |
04/22/2024
3:19 PM | TFF Pharmaceuticals (Filer)
| Form DEF 14A | |
04/22/2024
3:20 PM | TFF Pharmaceuticals (Filer)
| Form DEFA14A | |
04/18/2024
4:20 PM | TFF Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/08/2024
5:41 AM | TFF Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/28/2024
3:05 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:01 PM | TFF Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/22/2024
7:00 AM | TFF Pharmaceuticals (Filer)
| Form 424B5 | |
02/14/2024
5:48 PM | LYTTON LAURENCE W (Filed by)
TFF Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/19/2023
5:07 AM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
11:15 PM | TFF Pharmaceuticals (Filer)
| Form EFFECT | |
12/08/2023
3:52 PM | TFF Pharmaceuticals (Filer)
| Form S-3/A | |
12/04/2023
4:25 PM | Lee Catherine Chai-zon (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/04/2023
4:25 PM | Patane Michael A (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/04/2023
4:26 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2023
4:27 PM | Lee Catherine Chai-zon (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
4:28 PM | Patane Michael A (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
4:29 PM | ROCAMBOLI STEPHEN (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
4:30 PM | MILLS ROBERT S (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
4:31 PM | Roberts Brandi (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
4:14 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
3:41 PM | TFF Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/14/2023
3:06 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The 2024 Gold Rush: Unleashing Market Potential (Ad) Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. |
09/22/2023
3:16 PM | TFF Pharmaceuticals (Filer)
| Form PRE 14A | |
09/18/2023
4:20 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
3:10 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2023
4:27 PM | Asgard Investment Corp. II (Reporting)
CARLSON CAPITAL L P (Reporting)
Carlson Clint Duane (Reporting)
Double Black Diamond Offshore Ltd (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/17/2023
4:29 PM | Asgard Investment Corp. II (Reporting)
CARLSON CAPITAL L P (Reporting)
Carlson Clint Duane (Reporting)
Double Black Diamond Offshore Ltd (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
3:43 PM | TFF Pharmaceuticals (Filer)
| Form 424B5 | |
08/15/2023
7:00 AM | Mikhak Zamaneh (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
7:00 AM | MILLS ROBERT S (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
7:00 AM | COLEMAN KIRK ALLEN (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
7:00 AM | Roberts Brandi (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
7:00 AM | ROCAMBOLI STEPHEN (Reporting)
TFF Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
7:00 AM | TFF Pharmaceuticals (Issuer)
Weisman Harlan F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
5:11 AM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
5:02 AM | TFF Pharmaceuticals (Filer)
| Form 424B5 | |
06/23/2023
4:18 PM | TFF Pharmaceuticals (Filer)
| Form 424B5 | |
06/23/2023
4:15 PM | TFF Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
